뉴스
-
i-SENS Soars on Earnings, Peptron Rebounds, Cellid Hits Limit-Up[K-Bio Pulse]
South Korean pharmaceutical and biotechnology stocks were mixed Monday, with i-SENS soaring after reporting second quarter earnings that far exceeded market exp
www.edaily.co.kr · 2026.07.28
-
Deepnoid and Peptron Hit Daily Limit, L&C Bio Falls on Rights Offering[K-Bio Pulse]
South Korea's pharmaceutical and biotechnology sector received a boost on Aug. 3 as the KOSDAQ market posted strong gains. Buying momentum intensified, triggeri
www.edaily.co.kr · 2026.08.04
-
Antrogen Slides on Japan Fears, Hanmi Science Gains[K-Bio Pulse]
South Korean biopharmaceutical stocks moved in opposite directions on Tuesday, with Antrogen tumbling to the daily limit on concerns over the commercial potenti
www.edaily.co.kr · 2026.07.09
-
InBody Rallies on GLP-1 Buzz, Cellid Sinks[K-Bio Pulse]
Shares of South Korean biotech companies moved sharply in different directions on Monday as company-specific developments drove investor sentiment. InBody exten
www.edaily.co.kr · 2026.07.01
-
HLB Hits Limit-Up on FDA Optimism; Curiosis, Peptron Rebound Sharply [K-Bio Pulse]
On July 15, South Korean pharmaceutical and biotech stocks rallied, led by a broad surge in HLB affiliates, while Curiosis and Peptron posted double-digit gains
www.edaily.co.kr · 2026.07.16
-
Peptron Sinks on Fading Lilly Hopes; Nature Cell, BL Pharmtech Hit Limit-Up [K-Bio Pulse]
On July 9, South Korean pharmaceutical and biotech stocks saw sharply divergent moves, with Nature Cell and BL Pharmtech both hitting the daily upper limit, whi
www.edaily.co.kr · 2026.07.10
-
Rokit, AprilBio Hit Limit-Up...HanAll Jumps on Own Catalyst[K-Bio Pulse]
The biotech and healthcare sector saw a rare wave of positive momentum on June 24, helped by sentiment surrounding the 2026 BIO International Convention, or BIO
www.edaily.co.kr · 2026.06.25
-
Cellid Crashes After-Hours on Phase 3 Failure...Shaperon Dives 25%[K-bio pulse]
In the biopharmaceutical sector on Friday, Cellid’s stock surged on expectations for its vaccine clinical trial results, but the shares plunged by the dai
www.edaily.co.kr · 2026.06.29
-
HLB Jumps on FDA Review Hopes...Seers Rznomics Rally[K-Bio Pulse]
On June 16, South Korea’s pharmaceutical and biotechnology stocks traded largely on company-specific catalysts, including regulatory expectations, busines
www.edaily.co.kr · 2026.06.17
-
GI Innovation and Orient Bio Surge on Strong Data and Governance [K-Bio Pulse]
While the South Korean stock market continues to see foreign and institutional capital heavily concentrated in the semiconductor sector, the biotechnology segme
www.edaily.co.kr · 2026.06.14
